[{"orgOrder":0,"company":"Alloksys Life Sciences","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"NETHERLANDS","productType":"Other Large Molecule","year":"2023","type":"Inapplicable","leadProduct":"Alkaline Phosphatase","moa":"Undisclosed","graph1":"Immunology","graph2":"Phase III","graph3":"Alloksys Life Sciences","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Intravenous Infusion","sponsorNew":"Alloksys Life Sciences \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"Alloksys Life Sciences \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals by Alloksys Life Sciences

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Legal Affairs
                          Not Confirmed
                          Legal Affairs
                          Not Confirmed

                          Details : Rescap® (RESCuing Alkaline Phosphatase), is a proprietary medication developed by Alloksys, based on the enzyme alkaline phosphatase (AP). RESCAP® is derived from calf intestines and has been demonstrated to be safe and suitable for intravenous adminis...

                          Product Name : Rescap

                          Product Type : Other Large Molecule

                          Upfront Cash : Inapplicable

                          August 24, 2023

                          Lead Product(s) : Alkaline Phosphatase

                          Therapeutic Area : Immunology

                          Highest Development Status : Phase III

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank